CD4/CD8 Ratio: An Independent Predictor of Herpes Zoster in Patients With Autoimmune Inflammatory Rheumatic Diseases

키워드

참고문헌 (32)

1. Schmader K, "Herpes zoster", Ann Intern Med, 169, pp.ITC19~ITC31 (2018)
2. Weinberg A, "Comparative immune responses to licensed herpes zoster vaccines", J Infect Dis, 218, pp.S81~S87 (2018)
3. Chen SY, "Incidence of herpes zoster in patients with altered immune function", Infection, 42, pp.325~334 (2014)
4. Weinberg A, "Influence of age and nature of primary infection on varicella-zoster virus-specific cell-mediated immune responses", J Infect Dis, 201, pp.1024~1030 (2010)
5. Kolcava J, "The impact of lymphocytosis and CD4", CD8 ratio on the anti-JCV antibody index and clinical data in patients treated with natalizumab, 2021, pp.42, 2847~2853
6. Pérez-Saldívar M, "T-cell response against varicella zoster virus in patients with multiple sclerosis during relapse and remission", Int J Mol Sci, 23, pp.298~ (2021)
7. Serrano-Villar S, "HIV-infected individuals with low CD4", CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality, 2014, pp.10, e1004078~
8. Caby F, "CD4+", CD8+ ratio restoration in long-term treated HIV-1-infected individuals, 2017, pp.31, 1685~1695
9. Hughes RA, "Long terms trends in CD4+ cell counts, CD8+ cell counts, and the CD4+ : CD8+ ratio", AIDS, 32, pp.1361~1367 (2018)
10. Slight-Webb S, "Autoantibody-positive healthy individuals display unique immune profiles that may regulate autoimmunity", Arthritis Rheumatol, 68, pp.2492~2502 (2016)
11. Forbes HJ, "Quantification of risk factors for herpes zoster : population based case-control study", BMJ, 348, pp.g2911~ (2014)
12. Dolin R, "NIH conference. Herpes zoster-varicella infections in immunosuppressed patients", Ann Intern Med, 89, pp.375~388 (1978)
13. Yun H, "Risk of herpes zoster in autoimmune and inflammatory diseases : implications for vaccination", Arthritis Rheumatol, 68, pp.2328~2337 (2016)
14. Aringer M, "2019 European League Against Rheumatism", American College of Rheumatology classification criteria for systemic lupus erythematosus, 2019, pp.78, 1151~1159
15. Aletaha D, "2010 Rheumatoid arthritis classification criteria : an American College of Rheumatology", European League Against Rheumatism collaborative initiative, 2010, pp.62, 2569~2581
16. Shiboski SC, "American College of Rheumatology classification criteria for Sjögren’s syndrome: a data-driven, expert consensus approach in the Sjögren’s International Collaborative Clinical Alliance cohort", Arthritis Care Res(Hoboken), 64, pp.475~487 (2012)
17. van den Hoogen F, "2013 Classification criteria for systemic sclerosis : an American College of Rheumatology", European League Against Rheu-matism collaborative initiative, 2013, pp.72, 1747~1755
18. Hoogendijk JE, "119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The Netherlands", Neuromuscul Disord, 14, pp.337~345 (2004)
19. Sunderkötter CH, "Nomenclature of cutaneous vasculitis : dermatologic addendum to the 2012 revised international chapel hill consensus conference nomenclature of vasculitides", Arthritis Rheumatol, 70, pp.171~184 (2018)
20. Dasgupta B, "2012 Provisional classification criteria for polymyalgia rheumatica : a European League Against Rheumatism", American College of Rheumatology collaborative initiative, 2012, pp.71, 484~492
21. Higashida-Konishi M, "Allergic diseases in adult-onset still’s disease and rheumatoid arthritis", Arerugi, 70, pp.965~975 (2021)
22. Raychaudhuri SP, "The classification and diagnostic criteria of ankylosing spondylitis", J Autoimmun, 48-49, pp.128~133 (2014)
23. Singh JA, "Risk of serious infection in biological treatment of patients with rheumatoid arthritis : a systematic review and meta-analysis", Lancet, 386, pp.258~265 (2015)
24. Winthrop KL, "Rheumatoid arthritis and herpes zoster : risk and prevention in those treated with anti-tumour necrosis factor therapy", Ann Rheum Dis, 69, pp.1735~1737 (2010)
25. Jones D, "Varicella zoster virus productively infects human peripheral blood mononuclear cells to modulate expression of immunoinhibitory pro-teins and blocking PD-L1 enhances virus-specific CD8+ T cell effector function", PLoS Pathog, 15, pp.e1007650~ (2019)
26. Buggert M, "Multiparametric bioinformatics distinguish the CD4", CD8 ratio as a suitable laboratory predictor of combined T cell pathogenesis in HIV infection, 2014, pp.192, 2099~2108
27. De Zuani M, "High CD4-to-CD8 ratio identifies an at-risk population susceptible to lethal COVID-19", Scand J Immunol, 95, pp.e13125~ (2022)
28. Balshi A, "High CD4+ : CD8+ ratios with herpes zoster infections in patients with multiple sclerosis on dimethyl fumarate", Mult Scler, 29, pp.1465~1470 (2023)
29. Weinberg A, "The effect of age on the immunogenicity of the live attenuated zoster vaccine is predicted by baseline regulatory T cells and varicella-zoster virus-specific T cell immunity", J Virol, 93, pp.e00305~19 (2019)
30. Kang H, "Flow cytometric analysis of T lymphocytes and cytokines in aqueous humor of patients with varicella zoster virus-mediated acute retinal necrosis", BMC Ophthalmol, 21, pp.193~ (2021)
31. Krasselt M, "Humoral immunity to varicella zoster virus in patients with systemic lupus erythematosus and rheumatoid arthritis compared to healthy controls", Vaccines(Basel), 9, pp.325~ (2021)
32. Krasselt M, "Humoral immunity to varicella zoster virus is altered in patients with rheumatoid arthritis", Clin Rheumatol, 38, pp.2493~2500 (2019)

관련 논문AI추천